As technologies and treatments continue to advance, there are more and more options in the details of how each cancer patient is treated. I work with my colleagues in other disciplines to define the most appropriate treatment for each individual patient. For each individual I am treating with radiation, I make a concerted effort to survey the landscape of potential treatment choices that I am able to bring to a particular patient’s care to ensure that the most effective, precise and targeted approach is being used in every situation. This allows patients to get the maximum amount of benefit from treatment with as small a risk of complications as possible.
Resident, Stich Radiation Center, Weill Cornell Medical Center, New York, NY
MD, University of Massachusetts Medical School, Worcester, MA, 2005
BA, Haverford College, Haverford, PA, 1998
Board Certified, Radiation Oncology, American College of Radiology, 2011
American College of Radiology (ACR)
American Society of Clinical Oncology (ASCO)
American Society of Therapeutic Radiation Oncology (ASTRO)
Honors & Awards
ARRO Educator of the Year, 2015
Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009
Roentgen Resident/Fellow Research Award, 2009
Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009
American Radium Society Travel Grant, 2009
ASCO Cancer Foundation Merit Award, American Society of Clinical Oncology, 2009
International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
I’m 62 and I live in Bristol, Pa., with my wife Maryann. Between the two of us, we have four children and eight grandchildren (with another on the way). I also have a large extended family, and I work full time as a contractor. Needless to say, I’m a pretty busy guy!
I’m 45 and live in Delran, New Jersey, with my wife and two kids. I work as a vice president of business development for MasterCard, and in my spare time I love to run.
I’ve run marathons and completed an Ironman 70.3 (also known as a Half Ironman), which consists of a 1.2-mile swim, a 56-mile bike ride, and a 13.1-mile run. So, I’m no stranger to pain and discomfort.
My interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.
Meyer J.E., Reddy S., ASO author reflections: Neoadjuvant chemoradiation impacts the prognostic effect of surgical margin status in pancreatic adenocarcinoma. Ann Surg Oncol. 29(1): 364-365, 2022. PMC9036528. https://www.ncbi.nlm.nih.gov/pubmed/34091775.
Paly J.J., Deng M., Lee C.T., Hayes S.B., Galloway T.J., Hallman M.A., Weiss S.E., Horwitz E.M., Price R.A., Ma C.C., Meyer J.E., Pelvic reirradiation utilizing pulsed low-dose rate radiation therapy. Am J Clin Oncol. 43(10): 748-751, 2020. https://www.ncbi.nlm.nih.gov/pubmed/32769406.
Wong J.K., Handorf E., Lee D., Jain R., Zhang E., Cooper H.S., Farma J.M., Dotan E., Meyer J.E., Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer. J Geriatr Oncol. 11(8): 1331-1334, 2020. PMC7606716. https://www.ncbi.nlm.nih.gov/pubmed/32381438.
LS Wang, T Shaikh, EA Handorf, JP Hoffman, SJ Cohen, JE Meyer. Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation. Practical Radiation Oncology 90(1); 2015. PubMed
Shaikh T, Ruth K, Scoot WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. “Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.” Ann Thorac Surg, 99(1):270-6, 2015 PubMed
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. “HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.” J Gastrointest Cancer, 44(4):450-5; 2013. PubMed
Meyer JE, Cohen SJ. “Beyond First-Line Therapy: Combining Chemotherapy and Radioembolization for Hepatic Colorectal Metastases.” J Nucl Med Radiat Ther 2:1-6; 2011
Meyer JE, Sherr DL. “Reply to receptive anal intercourse as a potential risk factor for rectal cancer.” Cancer. 117:3284-5; 2011.
Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. “Increasing incidence of rectal cancer in patients aged younger than 40 years.” Cancer. 116:4354-9; 2010. PubMed
Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4; 2009. PubMed
Fitzgerald TJ, Simon E, Meyer JE. “Prostate carcinoma: opportunities for translational research” J Cell Biochem 91(3):433-42, 2004. PubMed